STAT3 and plasma cell myeloma: Furthermore, Atiprimod blocked IL-6-Stat3 pathway in myeloma cells and down-regulated cell proliferation and survival by decreasing levels of the antiapoptotic proteins Bcl-2, Bcl-XL and Mcl-1 [187].